A public-private partnership, the new fund will support efforts to acquire and preserve affordable housing in the Twin Cities....
NYS Entity Status
NYS Filing Date
APRIL 23, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC NOT-FOR-PROFIT CORPORATION
2014 - BERGEN SARATOGA PARTNERSHIP HOUSING DEVELOPMENT FUND COMPANY, INC.
AROUND THE WEB
- Greater Minnesota Housing Fund Launches Impact Investment Fund
By email@example.com (Matt Sinclair) - Thursday Jun 8, 2017
- ‘Pinnacle meet of the year’: Saratoga opens for 40-day event
By Tom Pedulla - Friday Jul 21, 2017
The late sports columnist Red Smith directed readers to Saratoga Race Course by writing, “From New York City you drive north for about 175 miles, turn left on Union Avenue and go back 100 years.” That captures this iconic track, which was selected by Sports Illustrated as one of the top 10 sports venues of...
- Charter shares soar after it says it’s not interested in Sprint
By Reuters - Monday Jul 31, 2017
U.S. cable operator Charter Communications Inc’s shares shot up nearly 14 percent on Monday after the company said it was not interested in buying wireless carrier Sprint Corp (S.N). A deal between the two could be complex and disruptive, analysts said, noting financing issues, complicated ownerships and the possibility of upending existing partnerships. A merger...
- Neighborhoods That Play Hard to Get
By STEFANOS CHEN - Friday Aug 11, 2017
In some New York neighborhoods, the housing stock is great, but turnover is so low, word of mouth is the best search engine.
- Trump Family Wedding Planner to Head New York’s Federal Housing Office
By YAMICHE ALCINDOR and J. DAVID GOODMAN - Friday Jun 16, 2017
The appointment of Lynne Patton, who planned Eric Trump’s wedding, to head the Department of Housing and Urban Development’s New York office, is raising eyebrows.
- Protagonist, Janssen Ink Development Deal for Crohn’s Disease Drug
By Frank Vinluan - Tuesday May 30, 2017
Protagonist Therapeutics’ work developing an inflammatory bowel disease drug that can be taken as a pill, rather than injected, now has fresh cash and the backing of a large pharmaceutical partner. Newark, CA-based Protagonist (NASDAQ: PTGX) has entered a partnership with Janssen Biotech to develop and commercialize its drug, PTG-200. Janssen is paying Protagonist $50 […]